Reuters Predicts Uptick in Medtech M&A (HealthPointCapital)
A new Reuters report predicts that medtech M&A will escalate in 2013, an uptick they attribute to the looming device tax and recent management transitions. Reuters speculates that as small companies become pressured by the 2.3% device tax, set to go into effect in January, buying opportunities could emerge for strategics. Further, recent management changes, including new CEOs at J&J and Medtronic, may have slowed M&A, which should reverse as new leaders settle into their organizations.
According to the report, medtech ...
